ask="0.5360"
ask_size="500"
average_daily_volume="3020930"
bid="0.4800"
bid_size="10000"
book_value="0.1680"
change="+0.0063"
change_from_200_day_moving_average="0.1639"
change_from_50_day_moving_average="0.1678"
change_from_52_week_high="-0.1557"
change_From_52_week_low="0.2343"
change_in_percent="+1.2402%"
close="0.5143"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.5143"
high_52_weeks="0.6700"
last_trade_date="2/24/2017"
last_trade_price="0.5143"
last_trade_size="131861"
last_trade_time="4:00pm"
low="0.4825"
low_52_weeks="0.2800"
market_capitalization="132.25M"
moving_average_200_day="0.3504"
moving_average_50_day="0.3465"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.4833"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+46.7605%"
percent_change_from_50_day_moving_average="+48.4395%"
percent_change_from_52_week_high="-23.2388%"
percent_change_from_52_week_low="+83.6786%"
previous_close="0.5080"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.0238"
price_per_sales="2.3981"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="PPHM"
volume="2470647"
weeks_range_52="0.2800 - 0.6700"
